IMDX
Insight Molecular Diagnostics Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.65
−3.28%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 26.62x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -4.07x
- Price / sales
- 51.93x
- Price / cash flow
- -3.22x
Enterprise value
- Enterprise value
- $71.6M
- EV / sales
- 42.87x
- EV / EBITDA
- -1.53x
- EV / EBIT
- -1.68x
- Market cap
- $86.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026